Analysis of immune infiltrates in a genomically characterized clinical cohort of head and neck squamous cell carcinoma (HNSCC) patients (pts).

被引：1
|
作者：
Chau, Nicole Grace
Li, Yvonne Y.
Hung, Yin P.
Hammerman, Peter S.
Rodig, Scott J.
Schoenfeld, Jonathan Daniel
Margalit, Danielle Nina
Lorch, Jochen H.
Rabinowits, Guilherme
Tishler, Roy B.
Haddad, Robert I.
Jo, Vickie Y.
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Div Hematopathol, Boston, MA 02115 USA
[4] Harvard Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Radiat Oncol, Boston, MA 02115 USA
[5] Harvard Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.6052
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6052
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Dickkopf-1 is a Prognostic Biomarker of Head and Neck Squamous Cell Carcinoma that Correlates with Immune Infiltrates
    Zhao, C.
    Jin, F.
    Li, Y.
    Liu, L.
    He, Q.
    Feng, J.
    Zeng, Z.
    Chen, Y.
    Li, Y.
    Xu, X.
    Zhu, S.
    Ye, Y.
    Zhou, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E281 - E281
  • [42] Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma
    Cui, Kun
    Yao, Xi
    Wei, Zhengbo
    Yang, Yujia
    Liu, Xinli
    Huang, Zhongheng
    Huo, Huimin
    Tang, Jinping
    Xie, Ying
    FRONTIERS IN GENETICS, 2022, 13
  • [43] CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma
    Zhang, Yijian
    Chen, Kai
    Li, Li
    Mao, Weidong
    Shen, Dong
    Yao, Ninghua
    Zhang, Lei
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
  • [44] Impact of comorbidity on outcome and treatment choice in patients with head and neck squamous cell carcinoma (HNSCC).
    Giacinti, Silvana
    Giannarelli, Diana
    Moi, Rossana
    Battista, Michele
    Perfetti, Alessandra
    Ferrari, Laura
    Alo, Piero Luigi
    Costanzo, Filippo
    Marzetti, Andrea
    Cognetti, Francesco
    Nistico, Cecilia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Immune profile of head and neck squamous cell carcinoma (HNSCC) patients can be used to assessment of radiotherapy response: transcriptome-based analysis
    Teresiak, A.
    Kolenda, T.
    Braska, A.
    Kozlowska-Maslon, J.
    Mantaj, P.
    Grzejda, N.
    Guglas, K.
    Poter, P.
    Dudek, K.
    Regulska, K.
    Blizniak, R.
    Kazimierczak, U.
    Lamperska, K.
    FEBS OPEN BIO, 2024, 14 : 286 - 287
  • [46] The Applications of Radiomics for Predicting Survival Rate of Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
    Park, Sang Won
    Kasani, Payam Hosseinzadeh
    Yeo, Na Young
    Kim, Gab-Jung
    Yoo, Se-Jong
    Kim, Jin Su
    JOURNAL OF MAGNETICS, 2020, 25 (04) : 587 - 594
  • [47] Pretreatment oral hygiene habits and survival of head and neck squamous cell carcinoma (HNSCC) patients
    Friemel, Juliane
    Foraita, Ronja
    Guenther, Kathrin
    Heibeck, Mathias
    Guenther, Frauke
    Pflueger, Maren
    Pohlabeln, Hermann
    Behrens, Thomas
    Bullerdiek, Joern
    Nimzyk, Rolf
    Ahrens, Wolfgang
    BMC ORAL HEALTH, 2016, 16
  • [48] Pretreatment oral hygiene habits and survival of head and neck squamous cell carcinoma (HNSCC) patients
    Juliane Friemel
    Ronja Foraita
    Kathrin Günther
    Mathias Heibeck
    Frauke Günther
    Maren Pflueger
    Hermann Pohlabeln
    Thomas Behrens
    Jörn Bullerdiek
    Rolf Nimzyk
    Wolfgang Ahrens
    BMC Oral Health, 16
  • [49] Impact of age on treatment outcomes of head and neck squamous cell carcinoma (HNSCC) patients.
    Juengsamarn, Jitlada
    Pattaranutaporn, Poompis
    Jiarpinitnun, Chuleeporn
    Chureemas, Teeranuch
    Ngamphaiboon, Nuttapong
    Chansriwong, Phichai
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Prognostic factors in early stage head and neck squamous cell carcinoma (HNSCC) patients in a prospective clinical trial.
    Kim, ES
    Lee, J
    Feng, L
    Lippman, S
    Shenouda, G
    Hodson, I
    Vokes, E
    Khuri, F
    Hong, WK
    Anderson, MD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 491S - 491S
12345